Ambey Laboratories Limited — Important, 06-08-2025: General Updates

Ambey Laboratories has secured in-principle approval from NSE for a preferential issue of 1.09 Crore fully convertible warrants. These warrants, priced at ₹10 each, will be allocated to both promoter and non-promoter groups. This move is a significant step towards capital raising, strengthening the company's financial position and supporting future growth. The approval is subject to standard compliance. Investors should note the potential equity dilution as warrants convert to shares.